Calls Purchased As ZIOPHARM Oncology Pops (ZIOP)

Shares of ZIOPHARM Oncology ZIOP are higher on the session by 4.70%, currently trading at $5.12. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short while ago the January 2011 $5.00 call was purchased 2,600 times, on the offer, on open interest of 3,520 contracts. Overall call volume is now running at 75.17x the daily average with 99% of all calls traded being purchases on the offer. ZIOPHARM Oncology, Inc. is a biopharmaceutical company. The company focuses on licensing and development of small molecule drug candidates that are related to cancer therapeutics already on the market or in development and that can be developed in intravenous and/or oral forms of administration.